Literature DB >> 8957992

Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy.

I D Harley1, E F Jones, G Liu, P R McCall, P L McNicol.   

Abstract

Orthotopic liver transplantation (OLT) in patients with end-stage liver disease is a procedure associated with high cardiac output, low systemic vascular resistance (SVR), coagulopathy and the potential for significant blood loss. A feature of hypertrophic obstructive cardiomyopathy (HOCM) is left ventricular outflow tract obstruction which may be exacerbated by reduced SVR, reduced filling pressures, tachycardia and positive inotropy. We report two cases of OLT in patients with HOCM. Our anaesthetic technique involved the use of halothane and vecuronium and avoidance of drugs causing tachycardia and positive inotropy. Management was aided by intraoperative transoesophageal echocardiography which showed that filling pressures poorly reflected end-diastolic volumes. Volume administration, vasoconstrictors and avoidance of inotropes and chronotropes reduced the outflow tract obstruction which was particularly severe in the reperfusion period.

Entities:  

Mesh:

Year:  1996        PMID: 8957992     DOI: 10.1093/bja/77.5.675

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 2.  Role of cardiovascular intervention as a bridge to liver transplantation.

Authors:  Zankhana Raval; Matthew E Harinstein; James D Flaherty
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Systolic anterior motion of mitral chordae tendineae: prevalence and clinical implications in liver transplantation.

Authors:  Hye-Mee Kwon; Kyoung-Sun Kim; Gyu-Sam Hwang
Journal:  Anesth Pain Med (Seoul)       Date:  2020-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.